These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33971725)

  • 21. Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma.
    Emamekhoo H; Dhillon P; Gopalakrishnan D; Elson P; Stephenson A; Magi-Galluzzi C; McKenney J; Harper H; Haber GP; Kaouk J; Lee B; Fergany A; Berglund R; Gong M; Stein R; Krishnamurthi V; Gilligan T; Ornstein M; Rini B; Garcia J; Grivas P
    Clin Genitourin Cancer; 2018 Aug; 16(4):e751-e760. PubMed ID: 29551583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
    Rouprêt M; Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Cowan NC; Dominguez-Escrig JL; Gontero P; Hugh Mostafid A; Palou J; Peyronnet B; Seisen T; Soukup V; Sylvester RJ; Rhijn BWGV; Zigeuner R; Shariat SF
    Eur Urol; 2021 Jan; 79(1):62-79. PubMed ID: 32593530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and Safety of Thulium Fiber Laser in the Conservative Management of Patients with Upper Tract Urothelial Carcinoma.
    Proietti S; Johnston T; Pupulin M; Di Pietro S; Spagna S; Rico L; Lucianò R; Ventimiglia E; Villa L; Gaboardi F; Giusti G
    Eur Urol Open Sci; 2022 Dec; 46():99-104. PubMed ID: 36506254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis.
    Kawada T; Laukhtina E; Quhal F; Yanagisawa T; Rajwa P; Pallauf M; von Deimling M; Bianchi A; Pradere B; Fajkovic H; Enikeev D; Gontero P; Rouprêt M; Seisen T; Araki M; Shariat SF
    Eur Urol Focus; 2023 Mar; 9(2):236-240. PubMed ID: 36463089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic management of upper tract urothelial cancer in a highly endemic area: A Taiwan nationwide collaborative study.
    Chen YT; Yeh HC; Lee HY; Hsieh PF; Chou EC; Tsai YC; Hong JH; Huang CY; Jiang YH; Lee YK; Tseng JS; Yu CC; Chiang BJ; Hsueh TY; Wu CC; Tsai CY
    Asian J Surg; 2023 Aug; 46(8):3058-3065. PubMed ID: 37525448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic Treatment for Large Multifocal Upper Tract Urothelial Carcinoma.
    Shvero A; Abu-Ghanem Y; Laufer M; Dotan ZA; Zilberman DE; Mor Y; Portnoy O; Fridmen E; Winkler H; Kleinmann N
    J Urol; 2021 Apr; 205(4):1039-1046. PubMed ID: 33216692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.
    Lee HY; Yeh HC; Wu WJ; He JS; Huang CN; Ke HL; Li WM; Li CF; Li CC
    World J Surg Oncol; 2018 Jul; 16(1):135. PubMed ID: 29986730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies.
    Mertens LS; Sharma V; Matin SF; Boorjian SA; Houston Thompson R; van Rhijn BWG; Masson-Lecomte A
    Eur Urol Open Sci; 2023 Mar; 49():60-66. PubMed ID: 36793750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
    Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
    J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [THE EFFICACY OF ENDOSCOPIC DUAL LASER TREATMENT FOR LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA].
    Shvero A; Zilberman DE; Laufer M; Dotan ZA; Ramon J; Winkler HZ; Kleinmann N
    Harefuah; 2020 Mar; 159(3):170-174. PubMed ID: 32186786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Liu J; Wu P; Lai S; Song X; Fu C; Wang X; Liu S; Hou H; Liu M; Wang J
    Clin Genitourin Cancer; 2021 Jun; 19(3):e156-e165. PubMed ID: 33121908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study.
    Wen J; Ji ZG; Li HZ
    BMC Cancer; 2018 Feb; 18(1):196. PubMed ID: 29454319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.
    Kang YC; Chen MH; Lin CY; Lin CY; Chen YT
    Ther Adv Drug Saf; 2021; 12():2042098621997727. PubMed ID: 33815744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologic surveillance intensity after endoscopic treatment of upper tract urothelial carcinoma.
    Basile G; Gallioli A; Martini A; Verri P; Robalino J; Dieguez L; Gavrilov P; Territo A; Uleri A; Gaya JM; Algaba F; Palou J; Breda A
    Minerva Urol Nephrol; 2024 Feb; 76(1):88-96. PubMed ID: 38426423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience.
    Fajkovic H; Klatte T; Nagele U; Dunzinger M; Zigeuner R; Hübner W; Remzi M
    World J Urol; 2013 Feb; 31(1):37-44. PubMed ID: 23014836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
    Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
    Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
    Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel laser therapies and new technologies in the endoscopic management of upper tract urothelial carcinoma: a narrative review.
    Myers AA; Pak RW
    Transl Androl Urol; 2023 Nov; 12(11):1723-1731. PubMed ID: 38106677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.